Thus, the roles of TRIB1 in chemotherapeutic responses in human breast cancer are critical and provide mechanistic insights into the importance of controlling myeloid TRIB 1 expression in breast cancer development (Kim et al., 2022). Here, TRIB1 is linked to breast carcinoma.